Catalyst Wire Dossier Catalyst Wire Dossier

Ganagliflozin

ganagliflozin · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ganagliflozin, covering 2025-11-18 to 2025-11-18. Get the full timeline:

Most recent: Clinical Trial Update: Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease [Phase 4]

See pricing